Global Biologic Medications for Psoriasis Market Growth 2024-2030

Global Biologic Medications for Psoriasis Market Growth 2024-2030

Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.

The global Biologic Medications for Psoriasis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Biologic Medications for Psoriasis Industry Forecast” looks at past sales and reviews total world Biologic Medications for Psoriasis sales in 2023, providing a comprehensive analysis by region and market sector of projected Biologic Medications for Psoriasis sales for 2024 through 2030. With Biologic Medications for Psoriasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Medications for Psoriasis industry.

This Insight Report provides a comprehensive analysis of the global Biologic Medications for Psoriasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Medications for Psoriasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologic Medications for Psoriasis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Medications for Psoriasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Medications for Psoriasis.

United States market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Biologic Medications for Psoriasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Biologic Medications for Psoriasis players cover Bristol-Myers Squibb, Amgen, Tiefenbacher Pharmaceuticals, UCB, Janssen Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Medications for Psoriasis market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
TNF-α Inhibitors
Interleukin Inhibitors
Tyrosine Kinase Inhibitors
Phosphodiesterase Inhibitors
Other

Segmentation by Application:
Hospital and Clinic
Retail Pharmacies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Amgen
Tiefenbacher Pharmaceuticals
UCB
Janssen Biotech
Eli Lilly
AbbVie Biotechnology
Dalian Yawei Pharmaceutical
Novartis
Ortho Dermatologics
LEO Pharma
Kyowa Kirin
Boehringer Ingelheim Pharmaceuticals
Pfizer
Samsung Bioepis
Qilu Pharmaceutical
Hanwha Chemical
China Medical System

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biologic Medications for Psoriasis market?

What factors are driving Biologic Medications for Psoriasis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biologic Medications for Psoriasis market opportunities vary by end market size?

How does Biologic Medications for Psoriasis break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.